Filter
846
Filtered Results: 846
Text search:
drug
prices
Featured
Recommendations
75
New Publications
260
Language
Document type
No document type
507
Studies & Reports
177
Guidelines
79
Strategic & Response Plan
38
Manuals
19
Fact sheets
8
Situation Updates
7
Training Material
4
Infographics
4
Resource Platforms
3
Countries / Regions
Global
34
India
32
Kenya
28
Uganda
21
Myanmar / Burma
21
South Africa
18
Nepal
17
Western and Central Europe
17
Liberia
16
Zambia
15
Malawi
15
Tanzania
13
Ukraine
13
Nigeria
12
Sierra Leone
11
Ghana
11
Bangladesh
11
Latin America and the Carribbean
11
Africa
11
Zimbabwe
9
Syria
9
Indonesia
9
Ethiopia
8
Philippines
8
Congo, Democratic Republic of
7
Namibia
7
Botswana
7
South–East Asia Region
7
Eastern Europe
7
Cameroon
6
Mozambique
6
Asia
6
Rwanda
5
Senegal
4
Haiti
4
Cambodia
4
Venezuela
4
Burkina Faso
3
Eswatini/ Swaziland
3
Lesotho
3
Tajikistan
3
Moldova
3
Guinea
2
Pakistan
2
Jordan
2
North Macedonia
2
Colombia
2
Bolivia
2
Middle East and North Africa
2
Paraguay
2
Albania
2
Russia
2
Kyrgyzstan
2
Georgia
2
USA
1
South Sudan
1
Afghanistan
1
Germany
1
Lebanon
1
Turkey
1
Thailand
1
China
1
Sudan
1
Benin
1
Central African Republic
1
Argentina
1
Peru
1
Brazil
1
Serbia
1
Libya
1
Sri Lanka
1
Chile
1
Eastern Europe and Central Asia
1
Bhutan
1
Palestine
1
North Korea
1
Armenia
1
Mongolia
1
Southern Africa
1
Laos
1
Timor Leste/ East Timor
1
Bulgaria
1
Estonia
1
Uzbekistan
1
Kazakhstan
1
Vietnam
1
Gabon
1
Turkmenistan
1
Authors & Publishers
Publication Years
Category
Countries
328
Clinical Guidelines
85
Public Health
51
Key Resources
20
Pharmacy & Technologies
19
Women & Child Health
18
Capacity Building
4
Toolboxes
HIV
110
Mental Health
80
Pharmacy
59
TB
49
AMR
47
COVID-19
33
Global Health Education
20
NCDs
18
Conflict
15
Health Financing Toolbox
15
NTDs
11
Planetary Health
10
Disability
8
Ebola
8
Refugee
8
Rapid Response
6
Caregiver
6
Polio
4
Natural Hazards
3
Cholera
2
Perspectives on Drugs
Accessed: 22.03.2019
A summary of the national drug situation
A summary of the national drug situation
Amphetamine-type stimulants, new psychoactive substances
-4-
World Drug Report 2017
Accessed: 14.03.2019
Opiates, cocaine, cannabis
World Drug Report 2017
-3-
Accessed: 14.03.2019
High prices, hard-to-access human insulin, few insulin producers, and weak health systems are just some of the barriers that people with diabetes face a century after insulin was discovered, WHO notes in a new report
1.HIV infections – drug therapy. 2.Anti-HIV agents – adverse effects. 3.Anti-retroviral agents. 4.Benzoxazines – adverse effects. 5.Pregnancy. 6.Disease transmission, Vertical - prevention and control. 7.Treatment outcome. I.World Health Organ...
In recent years, high prices of pharmaceutical products have posed challenges in high- and low-income countries alike. In many instances, high prices of pharmaceutical products have led to significa...
Review over the work and challenges of the Nigerian National Agency for Food and Drug Administration and Control (NAFDAC) in combatting counterfeiting of medicines in Nigeria.
The Pharmacovigilance team in WHO aims to assure the safety of medicines and vaccines by ensuring reliable and timely exchange of information on safety issues, promoting pharmacovigilance activities throughout the Organization and encouraging participation in the WHO Programme for International ... Monitoring. This text was developed in consultation with the WHO Collaborating Centre for International Drug Monitoring and the national pharmacovigilance centres participating in the WHO Programme for International Drug Monitoring.
The purpose of this manual is to define a limited number of indicators that will objectively describe the management and use of antimicrobials in hospitals and to provide tools and step-by-step instructions for designing and carrying out an assessment of antibiotic use and management in hospitals. T...
There is an urgent need for safer, simpler, more efficacious and accessible treatment regimens for all forms of TB. The development of Target Product Profiles for TB treatment regimens (referred to as Target Regimen Profiles or TRPs) seeks to guide the dru... development process towards important regimen characteristics corresponding to the needs of end-users.
Drugs and medical supplies are dispensed at the cutting edge level of the interface between the public health system and the people. Availability or lack of it brings either credit or discredit to the public health system. The primary reason for holding stocks of medicines and medical supplies in a ...
Direct acting antivirals (DAAs) have revolutionized treatment for hepatitis C. Combi-
nations of DAAs can cure infection with HCV in 12 weeks, are highly effective and
have limited side-effects. Affordability of DAAs has improved significantly, but access remains lim-
i...
Of the 50 antibiotics in the pipeline, 32 target WHO priority pathogens but the majority have only limited benefits when compared to existing antibiotics. Two of these are active against the multi-drug resistant Gram-negative bacteria, which are spr...
